Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03324659 · ClinicalTrials.gov registry record · NA

Meditation and Exercise to Treat Chronic Back Pain

A NA study of Chronic Low Back Pain, sponsored by Duquesne University.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT03324659 is a NA study of Chronic Low Back Pain that has completed, run by Duquesne University. The registered enrollment target is 42 participants, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03324659, a NA study of Chronic Low Back Pain, has completed, sponsored by Duquesne University.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

This study evaluates the analgesic effect of a combination treatment of exercise and mindfulness based meditation in patients with chronic back pain. Half of the participants will partake in a 4-week exercise and meditation intervention, while the other half will receive a placebo treatment. The investigators hypothesize that a combination treatment reduces disability and pain more than the control intervention.

Conditions Studied

Interventions

  • BEHAVIORAL Control
  • BEHAVIORAL Exercise and Meditation

Study Locations (1)

Pennsylvania

  • Duquesne University - Pittsburgh

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2018-01-26
Est. Completion 2019-06-30
Phase NA

Sponsor

Duquesne University

21 total trials

What the Registry Record Tells You About NCT03324659

The ClinicalTrials.gov registry entry for NCT03324659 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 591-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (93% lower). The listed sponsor is Duquesne University, which has 21 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Low Back Pain appearing as the primary indexed condition, and to 2 interventions - of which Control is the first listed.

NCT03324659 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03324659 about?

NCT03324659 is a clinical study titled "Meditation and Exercise to Treat Chronic Back Pain". This study evaluates the analgesic effect of a combination treatment of exercise and mindfulness based meditation in patients with chronic back pain. Half of the participants will partake in a 4-week exercise and meditation intervention, while the other half will receive a placebo treatment. The inv...

What is the current status of trial NCT03324659?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2018-01-26. Estimated completion is 2019-06-30.

What conditions does trial NCT03324659 study?

This clinical trial studies the following conditions: Chronic Low Back Pain.

What interventions are being tested in trial NCT03324659?

The interventions under investigation include: Control (BEHAVIORAL), Exercise and Meditation (BEHAVIORAL).

Who is sponsoring clinical trial NCT03324659?

This trial is sponsored by Duquesne University, which has 21 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03324659 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.